Novel Vaccine Therapy Shows Promise for Extending Survival Time in Patients with Deadly Glioblastoma
Monday, April 11, 2011 - 12:00
in Health & Medicine
Glioblastoma, or malignant glioma, is the most common malignant brain tumor, and also the most deadly, because it is very resistant to treatment. In general, current treatments have not yielded significant increases in survival rates, which is why research into novel therapies is so crucial. A novel brain tumor vaccine clinical trial study conducted at UCLA demonstrates a longer survival time in patients with glioblastoma.